ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1256

A Machine Learning Pipeline for Prediction of Bone Marrow Oedema Along the Sacroiliac Joints on Magnetic Resonance Imaging

Joris Roels1, Ann-Sophie Kathleen De Craemer2, Thomas Renson3, Manouk de Hooge4, Arne Gevaert1, Lennart Jans3, Nele Herregods3, Thomas Van Den Berghe3, Philippe Carron3, Filip Van den bosch5, Yvan Saeys1 and Dirk Elewaut6, 1Center for Inflammation Research, UGent-VIB, Ghent, Belgium, 2Ghent University Hospital, Gent, Belgium, 3Ghent University Hospital, Ghent, Belgium, 4Ghent University Hospital, Luxembourg, Luxembourg, 5Department of Internal Medicine and Paediatrics, Ghent University and VIB Centre for Inflammation Research, Ghent, Belgium, 6Department of Rheumatology, Ghent University Hospital, Belgium, VIB-UGent Center for Inflammation Research, Ghent University, Heusden, Belgium

Meeting: ACR Convergence 2022

Keywords: Imaging, Magnetic resonance imaging (MRI), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Detection and semi-quantitative assessment of bone marrow oedema (BMO) on magnetic resonance imaging (MRI) of the sacroiliac (SI) joints is essential for the diagnosis and follow-up of spondyloarthritis (SpA) patients. A machine learning (ML) algorithm could address intra- and inter-reader variability and the time-consuming nature of these assessments.

Methods: We developed a deep learning workflow that automatically locates the SI joints, segments regions of interest (ilium and sacrum), performs quadrant extraction and predicts presence of BMO, suggestive of inflammatory lesions, on a quadrant-level in semi-coronal slices of T1/T2 weighted MRI scans (Figure 1). Using a ResNet18 backbone, the inflammation classifier was trained and tested (5-fold cross-validation) on scans of SpA patients (n=279), postpartum women (n=71), and healthy individuals (n=114); while 243 SpA MRIs served as external validation. Patient-level predictions were derived from aggregating quadrant-level predictions, i.e. at least one positive quadrant.

Results: The proposed method automatically detects the SI joints and segments the ilium and sacrum. An area under the receiver operating characteristics curve (ROC AUC) score of 94.7%, balanced accuracy (B-ACC) of 82.2% and an F1 score of 62.1% is reported for the proposed inflammation prediction algorithm in cross validation. In the external validation dataset, ROC AUC was 88.2%, B-ACC 72.1% and F1 score 50.8%. On a patient-level, the model achieved an accuracy of 81.6% and 81.4% in the cross validation and external validation dataset, respectively.

Conclusion: We propose a fully automated ML pipeline for detection of BMO on MRI of the SI joints that has the potential to assist clinicians in early diagnosis and reliable quantification of inflammatory lesions in patients with (suspected) SpA.

Supporting image 1

Figure 1: Proposed pipeline for automated scoring of the MRI data. The T1-weightes sequence is used for locating the SI joints and segmentation of the ilium/sacrum. Based on this, the SI regions of interest (ROI) are extracted, and (optionally) masked with the ilium/sacrum segments. These ROIs are then fed to a convolutional neural network to predict presence of (deep) inflammatory lesions.


Disclosures: J. Roels, None; A. De Craemer, None; T. Renson, None; M. de Hooge, None; A. Gevaert, None; L. Jans, None; N. Herregods, None; T. Van Den Berghe, None; P. Carron, Biogen, AbbVie/Abbott, Eli Lilly, Fresenius Kabi, Galapagos, Merck/MSD, Pfizer, Sanofi, UCB; F. Van den bosch, AbbVie, Lilly, Galapagos, Janssen, Merck, Novartis, Pfizer, UCB, Amgen, Bristol-Myers Squibb(BMS), Celgene; Y. Saeys, None; D. Elewaut, AbbVie, Eli Lilly, Galapagos, Novartis, UCB Pharma.

To cite this abstract in AMA style:

Roels J, De Craemer A, Renson T, de Hooge M, Gevaert A, Jans L, Herregods N, Van Den Berghe T, Carron P, Van den bosch F, Saeys Y, Elewaut D. A Machine Learning Pipeline for Prediction of Bone Marrow Oedema Along the Sacroiliac Joints on Magnetic Resonance Imaging [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/a-machine-learning-pipeline-for-prediction-of-bone-marrow-oedema-along-the-sacroiliac-joints-on-magnetic-resonance-imaging/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-machine-learning-pipeline-for-prediction-of-bone-marrow-oedema-along-the-sacroiliac-joints-on-magnetic-resonance-imaging/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology